Why the study?
Does percutaneous balloon dilation improve transvalvar pressure gradient in patients with severe pulmonary valve stenosis presenting with or without congestive right heart failure and cyanosis?
Does percutaneous balloon dilation improve transvalvar pressure gradient in patients with severe pulmonary valve stenosis presenting with or without congestive right heart failure and cyanosis?
Percutaneous balloon dilation effectively reduces transvalvar gradients in severe pulmonary valve stenosis, but patients presenting late with right heart failure and cyanosis face high periprocedural risks including severe reperfusion injury.
Answers are grounded in this paper and cite their sources.
May support balloon dilation in severe PS; extends observational data to late presenters yet leaves periprocedural risks unresolved.
OBJECTIVES: This article reports outcomes of percutaneous balloon dilation in patients with severe pulmonary valve stenosis, in particular in those treated late with cyanosis, congestive heart failure, and pericardial effusion. BACKGROUND: Percutaneous balloon dilation is the treatment of choice for pulmonary valve stenosis. Although earlier intervention may produce better results, patients may present late with congestive heart failure and cyanosis. METHODS: Fifty-five patients who underwent pulmonary valve balloon dilation, were grouped into two groups, based on the presence or absence of congestive right heart failure and/or central cyanosis. Group I included 33 patients with severe pulmonary valve stenosis, but without clinical evidence of congestive right heart failure in the form of liver enlargement, raised jugular venous pressure, and peripheral edema and/or central cyanosis and group II included 22 patients with severe pulmonary valve stenosis and congestive right heart failure and/or central cyanosis. Their outcomes were compared. RESULTS: Doppler measured transvalvar pressure gradient decreased from 110.2 ± 34.0 mm Hg before to 52.5 ± 28.7 mm Hg in group I after dilation (P < 0.001), and from 138.4 ± 32.3 mm Hg to 53.9 ± 19.3 mm Hg in group II, (P < 0.001). Complications included ventricular tachycardia/fibrillation in three patients and severe bradycardia in one patient in group II. Twelve patients in group II developed clinical and radiologic evidence of reperfusion injury/pulmonary edema within the first 24 hr of intervention and needed ventilation for 2-9 days. Three of these patients died from intractable pulmonary edema. On follow up, clinical and echocardiographic improvement parameters were similar in the two groups. CONCLUSION: Those patients with severe pulmonary valve stenosis with congestive right heart failure, especially those with pericardial effusion, ascites and cyanosis, represent an important technical and clinical challenge. They are a high-risk group with or without treatment. If they survive the procedure, they may still remain at a high risk in the first few days afterward. Maintaining their ventilator and inotropic support after balloon dilation may increase survival. However, excellent results can be obtained.
No takes yet. Share an insight, caveat, or question.
Tefera et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: